Global Conjugate Vaccines Market (2017 - 2022)

The market for conjugate vaccines is expected to increase, owing to global awareness about the benefits of vaccination for the prevention of certain life-threatening diseases, growing initiatives for production of low-cost vaccines, and widespread routine vaccination programmes in emerging economies. The market will witness a steady growth, expanding at a compound annual growth rate (CAGR) of 11.7% during 2017-2022, to reach approximately USD 87.7 Bn by 2022.
Disease indication segment insights:
Pneumococcal conjugate vaccine (PCV) held the largest market share (24.66%) in 2017 owing to the widespread nature of pneumococcal disease. Also, the leading vaccine-preventable cause of death among children around the world is the pneumococcal disease. Global initiatives were undertaken to speed up the introduction of pneumococcal vaccinations in low-income countries through partnerships among countries, donors, academia, international organizations, and industries. Close on its heels, the diphtheria and tetanus toxoids and pertussis (DTP) conjugate vaccine occupied a share of 23% in 2017. The higher prevalence of respiratory diseases such as whooping cough, among both children and adults, have led to the increased adoption of DTP conjugate vaccines. Haemophilus influenzae type b (Hib) conjugate vaccines are expected to grow at the fastest rate during 2017-2022.
End user segment insights:
The adult segment registered higher market share than the paediatric segment because of an increase in awareness on conjugate vaccines for adults, over the years. Still, the penetration level for adult conjugate vaccines is comparatively lower, with the lowest being for PCVs. Hence, the growth potential is very high. The paediatric vaccines, on the other hand is a stable market and depends highly on the birth rates in each region. The vaccination programmes, especially taken up by global organizations such as the United Nations Educational, Scientific and Cultural Organization (UNESCO), have been successful in eradicating many such vaccine-preventable diseases.
Regional insights:
Asia-Pacific is the largest market for conjugate vaccines, which held a share of 42%, in 2017. The primary indicators of the potential for the vaccine market is the geriatric population in the region, especially in countries such as India and China. In turn, this has, encouraged market participants to increase spending on research and development (R&D) and distribution facilities in the these countries. North America is the second biggest market for conjugate vaccines, owing to the region's widespread immunization programmes. The Middle East and Africa, and Latin America regions lack proper infrastructure and awareness of vaccine-preventable diseases, which are hindering market growth.


Companies covered:
1. GlaxoSmithKline
2. Pfizer Inc.
3. Merck & Co.
4. Novartis
5. Sanofi Pasteur
6. CSL Limited
7. Bharat Biotech International
8. Biological E Limited
9. Serum Institute of India

Customizations available
With the given market data, Netscribes offers customizations according to specific needs. Write to us at [email protected], or connect with us here.
Chapter 1. Executive summary

1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary

Chapter 2. Global conjugate vaccine market - overview

2.1. Market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), geography-wise market revenue (USD Bn), and market attractiveness analysis
2.2. Market drivers
2.3. Market trends
2.4. Market challenges
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Segmentation based on disease indication (pneumococcal conugate vaccine (PCV), haemophilus influenzae type B (Hib) conjugate vaccine, diptheria, tetanus toxoids and pertussis (DTP) conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
2.8. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 3. North America conjugate vaccine market

3.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
3.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
3.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 4. Europe conjugate vaccine market

4.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
4.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
4.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 5. Asia-Pacific conjugate vaccine market

5.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
5.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
5.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 6. Latin America conjugate vaccine market

6.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
6.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
6.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 7. The Middle East and Africa conjugate vaccine market

7.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
7.2. Segmentation based on disease indication (pneumococcal conugate vaccine [PCV], haemophilus influenzae type B [Hib] conjugate vaccine, diptheria and tetanus toxoids and pertussis [DTP] conjugate vaccine, meningococcal conjugate vaccine, and others) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations
7.3. Segmentation based on end user (pediatric vaccine, and adult vaccine) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

Chapter 8. Competitive landscape

8.1. GlaxoSmithKline
8.1.a. Company snapshot
8.1.b. Products/services
8.1.c. Major initiatives/highlights
8.1.d. Growth strategy
8.1.e. Geographical presence
8.1.f. Key numbers
Note: Similar information areas will be covered for the remaining competitors:
8.2. Pfizer Inc.
8.3. Merck & Co.
8.4. Novartis
8.5. Sanofi Pasteur
8.6. CSL Limited
8.7. Bharat Biotech International
8.8. Biological E Limited
8.9. Serum Institute of India

Chapter 9. Conclusion
9.1. Future outlook

Appendix
1. List of tables
2. Research methodology
3. Assumptions
4. About Netscribes Inc.

Global Avian Influenza Vaccines Market Research Report 2019-2023

Published Date : Jul 2019

Avian influenza — known informally as avian flu or bird flu — refers to "influenza caused by viruses adapted to birds. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Avian Influenza Vaccines Report by Material, Applic...

Global DNA Vaccines Market Research Report 2019-2023

Published Date : Jul 2019

DNA vaccination is a technique for protecting an animal against disease by injecting it with genetically engineered DNA so cells directly produce an antigen, resulting in a protective immunological response. In the context of China-US trade war and global economic volatility and uncertainty, it will...

Global Oral Vaccines Market Research Report 2019-2023

Published Date : Jul 2019

An oral vaccine is one that is taken by mouth, instead of being injected directly into the blood. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Oral Vaccines Report by Material, Application, and Geography - Global Fo...

Global Veterinary Vaccines Market Research Report 2019-2023

Published Date : Jul 2019

Veterinary vaccines are used to prevent and treat animal diseases. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Veterinary Vaccines Report by Material, Application, and Geography - Global Forecast to 2023 is a profe...

Global HaemophilInfluenzae Type b Conjugate Vaccine Market Report 2019 - History, Present and Future

Published Date : Apr 2019

The global market size of HaemophilInfluenzae Type b Conjugate Vaccine is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024. Global HaemophilInfluenzae Type b Conjugate Vaccine Market Repor...

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

Published Date : Jun 2019

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. "United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025" presents an in...

Global Pharma & Vaccines Logistics Market Research Report 2019-2023

Published Date : Jun 2019

Logistics is a key component in the biopharmaceutical supply chain. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Pharma & Vaccines Logistics Report by Material, Application, and Geography - Global Forecast to 2023 i...

Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025

Published Date : Jun 2019

The global vaccines market size is expected to exceed US$ 48 Billion by the year-end of 2025. "Global Vaccines Market: Industry Size, Growth, Analysis and Forecast to 2025" presents an in-depth assessment of the global vaccines market dynamics, opportunities, future roadmap, competitive...

Global Antibody Drug Conjugate Market Research Report 2019-2023

Published Date : May 2019

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Antibody Drug Conjugate Repo...

Global Anthrax Vaccines Market Data Survey Report 2013-2025

Published Date : May 2019

Summary Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides. The global Anthrax Vaccines market will reach xxx Million USD in 2019 with CA...

 

Select License :

  • Single User : $2950

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.